Pro Medicus Limited Stock
Stocks
PME
AU000000PME8
Advanced Medical Equipment & Technology
OTC Markets Traded|
Delayed
Australian S.E.
01:47:04 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 165.70 AUD | -0.49% |
|
-4.07% | -24.99% |
| 08-20 | Pro Medicus' Unit Signs AU$25 Million Contract With US Health System | MT |
| 08-18 | Australia shares end flat as BHP, CSL offset banks' decline | RE |
| Market Cap | 17.4B 12.54B 10.79B 10.16B 9.26B 17.33B 1,194B 120B 46.55B 608B 47.1B 46.08B 1,926B | P/E 2027 * |
92.9x | P/E 2028 * | 72.7x |
|---|---|---|---|---|---|
| Enterprise Value | 17.1B 12.33B 10.61B 9.99B 9.1B 17.03B 1,173B 118B 45.77B 598B 46.31B 45.3B 1,894B | EV / Sales 2027 * |
50.5x | EV / Sales 2028 * | 40.5x |
| Free-Float |
51.04% | Yield 2027 * |
0.57% | Yield 2028 * | 0.69% |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| PME | Delayed | |
OTC Markets
| PMCUF | Delayed | |
|
Tradegate
| PMC | Real-time | |
|
Deutsche Boerse AG
| PMC | Delayed | |
|
Boerse Muenchen
| PMC | Real-time |
Last Transcript : Pro Medicus Limited
| 1 day | -0.50% | ||
| 1 week | -4.07% | ||
| Current month | -7.65% | ||
| 1 month | -6.19% | ||
| 3 months | +2.53% | ||
| 6 months | +18.60% | ||
| Current year | -24.99% |
| 1 week | 162.75 |  | 177.77 |
| 1 month | 162.75 | | 209.39 |
| Current year | 107.75 | | 223.02 |
| 1 year | 107.75 | | 321.57 |
| 3 years | 70.67 | | 336 |
| 5 years | 36.54 | | 336 |
| 10 years | 4.27 | | 336 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sam Hupert
CEO | Chief Executive Officer | - | 2010-09-30 |
Anthony Hall
CTO | Chief Tech/Sci/R&D Officer | - | - |
Danny English
DFI | Director of Finance/CFO | - | 2026-03-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Hall
BRD | Director/Board Member | - | 1982-12-31 |
Peter Kempen
CHM | Chairman | 75 | 2010-07-31 |
Anthony Glenning
BRD | Director/Board Member | - | 2016-04-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/25/26 | Buy | Founder | 8,146 | 0.0078% | ||
| 2/25/26 | Buy | Founder | 9,000 | 0.0086% | ||
| 2/24/26 | Buy | Founder | 8,500 | 0.0081% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.49% | -4.07% | -44.23% | +127.38% | 12.54B | |
| -1.53% | -7.10% | -7.74% | +18.38% | 42.23B | |
| -2.00% | -0.56% | -12.91% | +73.45% | 5.71B | |
| -2.26% | -6.66% | +34.50% | - | 4.06B | |
| -2.39% | -4.67% | - | - | 1.99B | |
| -0.71% | -3.08% | +2.65% | -37.32% | 1.53B | |
| -0.73% | -2.71% | -34.86% | - | 1.06B | |
| -0.19% | +1.37% | +19.40% | +146.19% | 1.02B | |
| +0.64% | -7.10% | +37.39% | +46.82% | 923M | |
| -3.07% | -3.07% | -31.29% | -48.13% | 801M | |
| Average | -1.27% | -3.40% | -4.12% | +46.68% | 7.19B | |
| Weighted average by Cap. | -1.39% | -5.50% | -11.72% | +44.63% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 339M 244M 210M 198M 180M 337M 23.24B 2.35B 906M 11.84B 917M 897M 37.5B | 420M 303M 261M 245M 224M 418M 28.81B 2.91B 1.12B 14.68B 1.14B 1.11B 46.5B |
| Net income | 186M 134M 115M 108M 98.83M 185M 12.74B 1.29B 497M 6.49B 503M 492M 20.56B | 239M 172M 148M 140M 127M 238M 16.39B 1.65B 639M 8.35B 647M 633M 26.45B |
| Net Debt | -293M -211M -182M -171M -156M -292M -20.12B -2.03B -785M -10.25B -794M -777M -32.48B | -405M -292M -251M -237M -216M -404M -27.8B -2.81B -1.08B -14.16B -1.1B -1.07B -44.86B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-10 | A$165.70 | -0.49% | 125,687 |
| 26-09-09 | A$166.51 | -1.82% | 187,831 |
| 26-09-08 | A$169.59 | +0.58% | 129,927 |
| 26-09-07 | A$168.61 | -3.07% | 106,580 |
| 26-09-04 | A$173.95 | +0.72% | 249,448 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PME Stock
Select your edition
All financial news and data tailored to specific country editions
